BlackRock, Inc. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though BlackRock, Inc. claims to own 14271784 shares. This represents 8.6% of PDL BioPharma.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!
Other recent filings from the company include the following:
Completion of Acquisition or Disposition of - Sept. 21, 2017
PDL BioPharma's President just picked up 240,200 shares - Sept. 13, 2017
PDL BioPharma's President just declared 0 ownership of the company. - Sept. 13, 2017
Securities to be offered to employees in employee benefit plans - Sept. 12, 2017
Current report, items 7.01 and 9.01 - Sept. 11, 2017